Literature DB >> 29580667

Retinal Degeneration in Choroideremia follows an Exponential Decay Function.

James W Aylward1, Kanmin Xue2, Maria I Patrício2, Jasleen K Jolly2, Jonathan C Wood1, Jonathan Brett1, Kirti M Jasani1, Robert E MacLaren3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29580667     DOI: 10.1016/j.ophtha.2018.02.004

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  12 in total

1.  Long-term Natural History of Atrophy in Eyes with Choroideremia-A Systematic Review and Meta-analysis of Individual-Level Data.

Authors:  Liangbo L Shen; Aneesha Ahluwalia; Mengyuan Sun; Benjamin K Young; Holly K Grossetta Nardini; Lucian V Del Priore
Journal:  Ophthalmol Retina       Date:  2020-03-14

2.  Macular spatial distribution of preserved autofluorescence in patients with choroideremia.

Authors:  Amir H Hariri; Michael S Ip; Aniz Girach; Byron L Lam; M Dominik Fischer; Eeva-Marja Sankila; Mark Edward Pennesi; Frank G Holz; Robert E Maclaren; David G Birch; Carel B Hoyng; Ian M MacDonald; Graeme C Black; Stephen H Tsang; Neil M Bressler; Kimberly E Stepien; Michael Larsen; Michael B Gorin; Isabelle Meunier; Andrew R Webster; SriniVas Sadda
Journal:  Br J Ophthalmol       Date:  2018-10-08       Impact factor: 4.638

3.  Progress in the development of novel therapies for choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Maria I Patrício; Robert E MacLaren
Journal:  Expert Rev Ophthalmol       Date:  2019-12-26

4.  Longitudinal Study to Assess the Quantitative Use of Fundus Autofluorescence for Monitoring Disease Progression in Choroideremia.

Authors:  Adam M Dubis; Wei S Lim; Jasleen K Jolly; Maria Toms; Robert E MacLaren; Andrew R Webster; Mariya Moosajee
Journal:  J Clin Med       Date:  2021-01-11       Impact factor: 4.241

5.  Bilateral visual acuity decline in males with choroideremia: a pooled, cross-sectional meta-analysis.

Authors:  Duygu Bozkaya; Heng Zou; Cindy Lu; Nicole W Tsao; Byron L Lam
Journal:  BMC Ophthalmol       Date:  2022-01-16       Impact factor: 2.209

6.  Ocular gene therapy for choroideremia: clinical trials and future perspectives.

Authors:  Kanmin Xue; Robert E MacLaren
Journal:  Expert Rev Ophthalmol       Date:  2018-05-18

Review 7.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

8.  Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia.

Authors:  Mariana Matioli da Palma; Fabiana Louise Motta; Caio Perez Gomes; Mariana Vallim Salles; João Bosco Pesquero; Juliana Maria Ferraz Sallum
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

Review 9.  Molecular Therapies for Choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Alun R Barnard; Robert E MacLaren
Journal:  Genes (Basel)       Date:  2019-09-23       Impact factor: 4.096

10.  Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?

Authors:  Ruofan Connie Han; Lewis E Fry; Ariel Kantor; Michelle E McClements; Kanmin Xue; Robert E MacLaren
Journal:  Expert Opin Orphan Drugs       Date:  2021-03-24       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.